Literature DB >> 22462327

[Thyroidectomy using the intra-operative neuromonitoring and the surgeon's confidence].

Rosario Sacco1, Ada Maria Lucisano, Nadia Innaro, Rosario Cardona, Francesco Lazzaro, Giuseppe Tomaino, Rita Gervasi, Vincenzo Orsini.   

Abstract

AIM: Reporting our experience with NIM-response 2.0 and 3.0 system in a series of 127 thyroidectomies. MATERIALS OF STUDY: 127 patients were operated at the "Magna Graecia" University (Catanzaro) from 2009 September to 2010 December, using the technique of IntraOperative NeuroMonitoring (IONM). For each patient the surgeon charge filled in a "questionnaire" assessing his/her compliance with the apparatus.
RESULTS: We report 0.8% permanent and 0.4% transient recurrent laryngeal nerve paralysis. All surgeons have been fully satisfied from IONM technique. DISCUSSION: A recurrent laryngeal nerve lesion may occur in patients operated on total thyroidectomy between 5-8% for transient palsies and 1-3% for the permanent ones. The use of IONM seems to contribute to a reduction of transient paralysis, even if this method is still not widely accepted Nevertheless the compliance of the surgeons with IONM seems to develop very highly.
CONCLUSIONS: NIM-response is helpful in protecting recurrent laryngeal nerve function. Advantages were observed in reduction of postoperative dysphonia and in improving the surgeon's confidence in performing a total thyroidectomy.

Entities:  

Mesh:

Year:  2012        PMID: 22462327

Source DB:  PubMed          Journal:  Ann Ital Chir        ISSN: 0003-469X            Impact factor:   0.766


  2 in total

1.  Medico legal aspects on neuromonitoring in thyroid surgery: informed consent on malpractice claims.

Authors:  R Demontis; M R Pittau; A Maturo; P Petruzzo; G Calò
Journal:  G Chir       Date:  2017 May-Jun

2.  Training in intraoperative neuromonitoring of recurrent laryngeal nerves reduces the risk of their injury during thyroid surgery.

Authors:  Dorota Kuryga; Piotr Wojskowicz; Jaroslaw Szymczuk; Anna Wojdyla; Anna J Milewska; Marcin Barczynski; Jacek Dadan; Marek Rogowski; Piotr Mysliwiec
Journal:  Arch Med Sci       Date:  2019-06-07       Impact factor: 3.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.